Panagora Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,192
| Closed | -$83K | – | 3169 |
|
|
2021
Q1 | $83K | Sell |
2,192
-3,282
| -60% | -$81.8K | ﹤0.01% | 2077 |
|
|
2020
Q4 | $93K | Sell |
5,474
-188,751
| -97% | -$2.36M | ﹤0.01% | 1863 |
|
|
2020
Q3 | $913K | Buy |
194,225
+102,098
| +111% | +$519K | 0.01% | 934 |
|
|
2020
Q2 | $562K | Buy |
92,127
+89,943
| +4,118% | +$370K | ﹤0.01% | 1158 |
|
|
2020
Q1 | $5K | Hold |
2,184
| – | – | ﹤0.01% | 2279 |
|
|
2019
Q4 | $10K | Sell |
2,184
-315,040
| -99% | -$1.25M | ﹤0.01% | 2138 |
|
|
2019
Q3 | $1.23M | Buy |
317,224
+133,291
| +72% | +$731K | 0.01% | 940 |
|
|
2019
Q2 | $1.11M | Buy |
183,933
+170,098
| +1,229% | +$1.63M | 0.01% | 1092 |
|
|
2019
Q1 | $185K | Buy |
+13,835
| New | +$158K | ﹤0.01% | 1736 |
|
|
2018
Q3 | – | Sell |
-13,515
| Closed | -$214K | – | 2499 |
|
|
2018
Q2 | $214K | Sell |
13,515
-48,916
| -78% | -$854K | ﹤0.01% | 1641 |
|
|
2018
Q1 | $1.07M | Buy |
+62,431
| New | +$1.22M | ﹤0.01% | 1134 |
|
|
2017
Q3 | – | Sell |
-2,861
| Closed | -$86K | – | 2581 |
|
|
2017
Q2 | $86K | Hold |
2,861
| – | – | ﹤0.01% | 1925 |
|
|
2017
Q1 | $103K | Sell |
2,861
-8,921
| -76% | -$393K | ﹤0.01% | 1860 |
|
|
2016
Q4 | $590K | Buy |
11,782
+7,178
| +156% | +$377K | ﹤0.01% | 1388 |
|
|
2016
Q3 | $242K | Buy |
+4,604
| New | +$220K | ﹤0.01% | 1708 |
|
|
2016
Q2 | – | Sell |
-287
| Closed | -$12K | – | 2373 |
|
|
2016
Q1 | $12K | Sell |
287
-1,753
| -86% | -$60.3K | ﹤0.01% | 2196 |
|
|
2015
Q4 | $85K | Buy |
2,040
+693
| +51% | +$23.2K | ﹤0.01% | 1839 |
|
|
2015
Q3 | $21K | Buy |
+1,347
| New | +$28.9K | ﹤0.01% | 2135 |
|
|
2014
Q3 | – | Sell |
-2,655
| Closed | -$41K | – | 2388 |
|
|
2014
Q2 | $41K | Sell |
2,655
-26,206
| -91% | -$376K | ﹤0.01% | 2135 |
|
|
2014
Q1 | $567K | Sell |
28,861
-25,218
| -47% | -$428K | ﹤0.01% | 1385 |
|
|
2013
Q4 | $908K | Buy |
+54,079
| New | +$672K | ﹤0.01% | 1205 |
|
Panagora Asset Management's FPRX Position: Q2 2021 in Review
Panagora Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 2,192 shares — an estimated $83K sold.
Panagora Asset Management first reported a position in FPRX in Q4 2013 and held it in 21 quarters. The position peaked at $1.23M in Q3 2019. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Panagora Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Panagora Asset Management sold 2,192 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $83K.
- Panagora Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and held it in 21 quarters.
- Panagora Asset Management's Five Prime Therapeutics, Inc. position peaked at $1.23M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.